Newsfeeds - Spark Newswire

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

Today, 2:08 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

4 minute read

Gamida Cell Highlights Publication In Blood, The Journal Of The American Society Of Hematology, Of First Pivotal Trial To Evaluate a Cell Therapy (Omidubicel) For Patients With Blood Cancer Who Require Allogeneic Stem Cell Transplant

By Bill Haddad

Today, 2:08 PM

Omidubicel is a first-in-class, NAM-enabled, advanced cell therapy being evaluated as a potential life-saving treatment for patients with blood cancers in need of an allogeneic hematopoietic stem cell (bone marrow)

GMDA